Top

Resverlogix Corp.

TSX Exchange | Oct 20, 2019, 5:41 AM EDT | Real-time price

RVX $ 1.46 RT
CHANGE
-0.02 (-1.3514%)
VOLUME
118,198
Day Low: 1.33
Day High: 1.54

News Headlines for Resverlogix Corp.loading

    Monday, September 30, 2019
    Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
    - GlobeNewswire , 7:30 AM EDT
    Friday, September 27, 2019
    Resverlogix Announces US$12 Million Debenture Financing and Full Repayment of Loan
    - GlobeNewswire , 9:27 AM EDT
    Thursday, September 26, 2019
    Resverlogix to Host BETonMACE Webcast and Conference Call
    - GlobeNewswire , 7:04 PM EDT
    Toronto Stock Exchange Introduces the TSX30
    - Canada Newswire , 9:00 AM EDT
    Monday, September 16, 2019
    Resverlogix Provides Update on BETonMACE Phase 3 Trial
    - GlobeNewswire , 8:30 AM EDT
    Thursday, August 22, 2019
    Resverlogix Announces Annual and Special Meeting of Shareholders
    - GlobeNewswire , 5:24 PM EDT
    Wednesday, August 14, 2019
    Resverlogix to Present at the European Society of Cardiology's ESC Congress 2019
    - GlobeNewswire , 8:30 AM EDT
    Friday, August 2, 2019
    Resverlogix Announces Loan Reduction and Extension
    - GlobeNewswire , 12:02 PM EDT
    Monday, July 15, 2019
    Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
    - GlobeNewswire , 8:30 AM EDT
    Wednesday, June 12, 2019
    Resverlogix Provides Update on BETonMACE Phase 3 Epigenetics Trial
    - GlobeNewswire , 8:30 AM EDT
    Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia. See the QuoteMedia Terms of Use.